This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, including antidepressants and anxiolytics. Its specific structure allows for the creation of chiral molecules, which are essential for producing enantiomerically pure substances with higher efficacy and reduced side effects. Additionally, it is employed in research and development for designing novel therapeutic agents, particularly in the field of neuropharmacology. Its application extends to the preparation of compounds used in preclinical studies to evaluate their pharmacological properties and potential clinical benefits.